FDA Adverse Event Injury Summary report: N

GORE EXCLUDER AAA ENDOPROSTHESIS

MDR report key: 2920147 · Received January 8, 2013

Report

Report Number
2953161-2013-00004
Event Type
Injury
Date Received
January 8, 2013
Date of Event
October 23, 2012
Report Date
December 13, 2012
Manufacturer
W. L. GORE & ASSOCIATES
Product Code
MIH
PMA / PMN Number
P020004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL EXCLUDER COMPONENT INCLUDED IN THIS REPORT PCC141000/022804602. RESULTS: A REVIEW OF THE MANUFACTURING RECORDS FOR THE DEVICES VERIFIED THAT THE LOTS MET ALL PRE-RELEASE SPECIFICATIONS. CONCLUSIONS: ANEURYSM GROWTH IN THE ABSENCE OF ENDOLEAK HAS BEEN DEFINED AS ENDOTENSION. ONE HYPOTHESIS FOR THE SOURCE OF ENDOTENSION IS THE TRANSMURAL MOVEMENT OF SEROUS FLUID ACROSS THE MATERIAL USED TO FABRICATE DEVICES USED TO TREAT THE AORTIC ABDOMINAL ANEURYSM. IN RESPONSE TO THIS ISSUE, GORE ELECTED IN 2004 TO PROVIDE A DESIGN ENHANCEMENT TO THE ORIGINAL GORE EXCLUDER BIFURCATED ENDOPROSTHESIS.

Description of Event or Problem · 1

ON (B)(6) 2003, THE PATIENT WAS IMPLANTED WITH TWO GORE EXCLUDER AAA ENDOPROSTHESES TO TREAT AN ABDOMINAL AORTIC ANEURYSM. ON AN UNKNOWN DATE, FOLLOW-UP IMAGING REVEALED CONTINUED EXPANSION OF THE ANEURYSM (FROM 6.1 TO 6.3 CM). NO EVIDENCE OF AN ENDOLEAK WAS DETECTED. ON (B)(6) 2012, THE PHYSICIAN EXPLANTED THE EXISTING STENT-GRAFT SYSTEM, AND SURGICALLY REPAIRED THE ANEURYSM. THE PATIENT TOLERATED THE PROCEDURE. THE EXPLANTED EXCLUDER DEVICES WERE DESTROYED AT THE FACILITY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
10336 GORE EXCLUDER AAA ENDOPROSTHESIS MIH / SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH W. L. GORE & ASSOCIATES 030134503

Patients

Seq Age Sex Outcome Treatment
1 67 YR Hospitalization| R ASPIRIN| VITAMIN B12| NORVASC| PRAVACHOL| TYLENOL WITH CODEINE| COUMADIN| ATENOLOL